The aim of this study was to ascertain whether the hyposideraemia in patients with rheumatoid arthritis is related to increased stores of iron and whether the depletion of stored iron that results from treatment with desferrioxamine restores the iron available for erythropoiesis. The preliminary data suggest the possible usefulness of desferrioxamine to treat rheumatoid arthritis by removing iron from synovial membrane, decreasing synovial inflammation, restoring stores in bone marrow, and lessening anaemia.
No takes yet. Share an insight, caveat, or question.
Giordano et al. (1984) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: